Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Clinical trial NCT06855277 · RECRUITING

Trial details

NCT number: NCT06855277
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-07-01
Primary completion: 2028-09-29
Enrollment: 940

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.